UPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates

Rhea-AI Summary

Jaguar Health, Inc. (NASDAQ:JAGX) announced an investor webcast on May 10, 2022, at 8:30 AM ET to discuss first-quarter 2022 financial results and corporate updates. The company plans to file its Earnings Report on Form 10-Q for the quarter ending March 31, 2022. The previous release incorrectly stated the date as March 10. Jaguar Health focuses on developing plant-based, non-opioid pharmaceuticals for gastrointestinal distress in humans and animals. For more details, register here.

Click here to register for webcast

Company plans to file its Earnings Report on May 10, 2022 on Form 10-Q for the quarter ended March 31, 2022

SAN FRANCISCO, CA / ACCESSWIRE / May 5, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that company management will host an investor webcast on Tuesday, May 10, 2022, at 8:30 a.m. Eastern Time to review first-quarter 2022 financials and provide corporate updates. (The release issued previously today mistakenly referred to "March 10" rather than "May 10" in the prior sentence).

Participation Instructions for Webcast

When: Tuesday, May 10, 2022, at 8:30 AM Eastern Time

Participant Registration & Access Link: Click Here

About Jaguar Health, Jaguar Animal Health, Napo Pharmaceuticals, & Napo Therapeutics

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea. Jaguar Animal Health is a tradename of Jaguar Health. Jaguar Health's wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human pharmaceuticals from plants harvested responsibly from rainforest areas. Our crofelemer drug product candidate is the subject of the OnTarget study, an ongoing pivotal Phase 3 clinical trial for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy. Jaguar Health is the majority shareholder of Napo Therapeutics S.p.A. (f/k/a Napo EU S.p.A.), an Italian corporation established by Jaguar Health in Milan, Italy in 2021 that focuses on expanding crofelemer access in Europe.

For more information about Jaguar Health, please visit https://jaguar.health. For more information about Napo Pharmaceuticals, visit www.napopharma.com.

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar Health's expectation that an investor webcast will take place May 10, 2022. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

Peter Hodge
Jaguar Health, Inc.
phodge@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

View source version on accesswire.com:
https://www.accesswire.com/700329/UPDATED-RELEASE-Jaguar-Health-to-Host-Investor-Webcast-Tuesday-May-10th-at-830-AM-Eastern-Time-Regarding-Q1-2022-Financials-Corporate-Updates

FAQ

What is the date of Jaguar Health's investor webcast?

The investor webcast for Jaguar Health is scheduled for May 10, 2022.

What time will the webcast about Q1 2022 financials start?

The webcast will start at 8:30 AM Eastern Time.

What financial report will Jaguar Health file on May 10, 2022?

Jaguar Health plans to file its Earnings Report on Form 10-Q for the quarter ended March 31, 2022.

Where can I register for the Jaguar Health webcast?

You can register for the Jaguar Health webcast by clicking here.

What is the focus of Jaguar Health's pharmaceuticals?

Jaguar Health focuses on developing plant-based, non-opioid pharmaceuticals for gastrointestinal distress.